Vitamin c

InterventionApproved 20172 papers1 findingPubChem 54670067ChEBI 29073

  • Humans1

Outcomes

1

Mortality

downin humans1Low certainty

1 study
  1. Vitamin c decreases mortality in humans.

    Humans

    Vitamin intake and colorectal cancer incidence and mortality: evidence from a large prospective cohort · Frontiers in nutrition · 9 Sep 2026

Trials

254

Approved

  • FDA · Ascor

    2 Oct 2017 · 1. INDICATIONS AND USAGE ASCOR is vitamin C indicated for the short term (up to 1 week) treatment of scurvy in adult and pediatric…

In trials

40 of 127
  • Iron-Deficiency Anemia

    Phase 4 · Completed · 3 trials

  • Pneumonia

    Phase 4 · Recruiting · 3 trials

  • Acute kidney injury

    Phase 4 · Status unknown · 2 trials

  • Chronic Renal Insufficiency

    Phase 4 · Results posted · 2 trials

  • Colonoscopy

    Phase 4 · Completed · 2 trials

  • Complex Regional Pain Syndromes

    Phase 4 · Completed · 2 trials

  • Fatigue

    Phase 4 · Status unknown · 2 trials

  • Human Influenza

    Phase 4 · Results posted · 2 trials

  • Pain

    Phase 4 · Terminated · 2 trials

  • Wounds and Injuries

    Phase 4 · Completed · 2 trials

  • Male infertility

    Phase 4 · Active, not recruiting · 1 trial

  • Prehypertension

    Phase 4 · Results posted · 1 trial

  • Renal insufficiency

    Phase 4 · Completed · 1 trial

  • Type 1 diabetes

    Phase 4 · Completed · 1 trial

  • Neoplasm

    Phase 3 · Completed · 8 trials

  • Colorectal neoplasm

    Phase 3 · Completed · 7 trials

  • Coronavirus Infections

    Phase 3 · Completed · 6 trials

  • Heart disease

    Phase 3 · Completed · 4 trials

  • Obesity

    Phase 3 · Completed · 4 trials

  • Pre-eclampsia

    Phase 3 · Results posted · 4 trials

  • Anemia

    Phase 3 · Results posted · 3 trials

  • Diabetes mellitus

    Phase 3 · Completed · 3 trials

  • Attention Deficit Disorder with Hyperactivity

    Phase 3 · Completed · 2 trials

  • Chronic Kidney Failure

    Phase 3 · Status unknown · 2 trials

  • Colonic Neoplasms

    Phase 3 · Completed · 2 trials

  • Coronary artery disease

    Phase 3 · Completed · 2 trials

  • Coronary Disease

    Phase 3 · Completed · 2 trials

  • Fragile X Syndrome

    Phase 3 · Completed · 2 trials

  • Impulsive Behavior

    Phase 3 · Completed · 2 trials

  • Myocardial ischemia

    Phase 3 · Completed · 2 trials

  • Restless Legs Syndrome

    Phase 3 · Status unknown · 2 trials

  • Stomach neoplasm

    Phase 3 · Status unknown · 2 trials

  • Vascular disease

    Phase 3 · Completed · 2 trials

  • Cataract

    Phase 3 · Status unknown · 1 trial

Stopped

  • NCT03335124 · Terminated · Sepsis

    Due to insufficient recruitment

  • NCT04472000 · Terminated · Pain

    The study had to be stopped due to difficulties in recruiting patients.

  • NCT04138394 · Suspended · Shock

    After the 1st interim analysis, on the recommendation of the DSMC, the steering committee decided to stop enrollment of new patients. The study is ongoing for the currently enrolled patients. More info to follow when available for public disclosure.

  • NCT00515736 · Terminated · Subarachnoid hemorrhage

    enrollment was completed

  • NCT01555489 · Terminated · Pancreatic Neoplasms

    Slow accrual

  • NCT00803530 · Terminated · Myelodysplastic syndrome

    difficulties of enrollement

All 23
  • NCT00227682 · Terminated · Multiple myeloma

    Terminated early due to funding suspension by grant sponsor.

  • NCT00184054 · Terminated · Leukemia, Myeloid, Acute

    Competing studies

  • NCT02516670 · Terminated · Prostatic Neoplasms

    insufficient clinical response per DSMB

  • NCT05501548 · Terminated · Prostatic Neoplasms

    The study was terminated by the IRB due to low accrual,

  • NCT06068543 · Suspended · Frailty

    The study has been suspended by the IRB pending review of a study-related issue

  • NCT02791906 · Terminated · Heart failure

    lack of funding

  • NCT03468075 · Terminated · Sarcoma

    Stopping rules met

  • NCT00626444 · Terminated · non-Hodgkin lymphoma

    Slow accrual

  • NCT03334409 · Terminated · Renal cell carcinoma

    Due to loss of funding from the private foundation source

  • NCT04264533 · Terminated · Viral pneumonia

    the study was started in the second half of the outbreak, and the number of qualifying COVID-19 patients decreased with the control of the epidemic so that we had to stop our trial before reaching the predefined sample size.

  • NCT01550510 · Terminated · Gastrointestinal disease

    Closed: low enrollment, many treatment options available for Colorectal Cancer

  • NCT02762331 · Terminated · Atrial fibrillation

    Therapy shown effective by larger studies

  • NCT01014546 · Terminated · Essential thrombocythemia

    low accrual

  • NCT00491751 · Terminated · Peripheral arterial disease

    Insufficient enrollment

  • NCT04001647 · Terminated · Aneurysm

    IRB approval has been withdrawn

  • NCT03228238 · Terminated

    The study was terminated early due to slow recruitment and the Principal Investigator's retirement.

  • NCT03889158 · Terminated

    COVID-19

Trial sponsors

Latest

Nov 2025: 0Dec 2025: 2Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 7Oct 2026: 112